US 9808505
Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)
granted A61KA61K31/4439A61K31/5377
Quick answer
US patent 9808505 (Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)) held by The Board of Regents of the University of Texas System expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/4439, A61K31/5377, A61K38/177, A61K38/191